Nestlé Health Science, Codexis to Develop PKU Enzyme in Protein Platform Partnership

Nestlé Health Science will use Codexis’ CodeEvolver ® protein engineering platform through a multiproject partnership that includes Nestlé gaining an option for global development of Codexis’ lead biotherapeutic candidate, phenylketonuria (PKU) candidate CDX-6114, the companies said today.Using CodeEvolver—designed to enable rapid development of highly optimized proteins, custom-designed for specific applications—Nestlé Health Science aims to disc